Disposition of methadone in methadone maintenance
- PMID: 1120392
- DOI: 10.1002/cpt1975173258
Disposition of methadone in methadone maintenance
Abstract
Six detoxified opiate addicts housed in a closed metabolic ward received methadone in stepwise increasing doses of 10, 20, 40, and 80 mg/day during 1 month. Four were given 14C-methadone at the lowest dose and again at the highest dose. Of the subjects receiving radiomethadone, 2 excreted the major part of the radioactivity in urine and 2 about equally in urine and feces. In addition to methadone, 7 metabolites were isolated and identified in urine and 3 metabolites in feces. About 75% of the urinary and fecal radioactive metabolites were unconjugated. Urinary excretion of methadone and its major N-monomethylated metabolite accounted for 17% to 57% of the given dose. The ratio of metabolite to parent drug increased in 5 of 6 subjects, and the urinary recovery of unchanged methadone decreased during the period. The results indicate that enhanced demethylation of methadone may occur during oral administration to man.
Similar articles
-
Effects of desipramine treatment on the biliary, fecal and urinary excretion of methadone in the rat.J Pharmacol Exp Ther. 1976 Aug;198(2):308-17. J Pharmacol Exp Ther. 1976. PMID: 948028
-
Effects of liver disease on fecal excretion of methadone and its unconjugated metabolites in maintenance patients. Quantitation by direct probe chemical ionization mass spectrometry.Biomed Mass Spectrom. 1983 Oct;10(10):544-9. doi: 10.1002/bms.1200101003. Biomed Mass Spectrom. 1983. PMID: 6652228
-
l-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites.Life Sci. 1974 Apr 16;14(8):1437-46. doi: 10.1016/0024-3205(74)90154-4. Life Sci. 1974. PMID: 4829538 No abstract available.
-
Drug interactions with methadone.Ann N Y Acad Sci. 1976;281:350-71. doi: 10.1111/j.1749-6632.1976.tb27945.x. Ann N Y Acad Sci. 1976. PMID: 798526 Review. No abstract available.
-
Therapeutic drug monitoring for methadone: scanning the horizon.Eur Addict Res. 1999 Mar;5(1):36-42. doi: 10.1159/000018961. Eur Addict Res. 1999. PMID: 10085499 Review.
Cited by
-
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.Br J Clin Pharmacol. 2000 Nov;50(5):427-40. doi: 10.1046/j.1365-2125.2000.00272.x. Br J Clin Pharmacol. 2000. PMID: 11069437 Free PMC article.
-
Effect of urinary pH on the disposition of methadone in man.Eur J Clin Pharmacol. 1982;22(4):337-42. doi: 10.1007/BF00548403. Eur J Clin Pharmacol. 1982. PMID: 6286317
-
Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.J Pharmacokinet Pharmacodyn. 2006 Aug;33(4):485-518. doi: 10.1007/s10928-006-9018-0. Epub 2006 Jun 7. J Pharmacokinet Pharmacodyn. 2006. PMID: 16758333
-
Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.Eur J Clin Pharmacol. 1982;22(4):343-9. doi: 10.1007/BF00548404. Eur J Clin Pharmacol. 1982. PMID: 7106170
-
Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.Drug Metab Dispos. 2012 Sep;40(9):1765-70. doi: 10.1124/dmd.112.045971. Epub 2012 Jun 8. Drug Metab Dispos. 2012. PMID: 22685215 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases